跳至主要内容
临床试验/NCT05079386
NCT05079386已完成不适用

Early Clinical Feasibility Study of a New Voice Prosthesis

Atos Medical AB2 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2022年1月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
17
试验地点
2
主要终点
Patient acceptability

研究概览

简要总结

The objective of this clinical investigation is to evaluate the short-term clinical feasibility of a new voice prosthesis and explore its acceptability, limitations and advantages. As a result of the evaluations, design changes may be implemented and evaluated until the optimal design has been determined, or until it is decided not to pursue further development of the device. Main outcome will be the patient's acceptance of the voice prosthesis, secondary outcomes are stickiness of the valve mechanism and speech.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Laryngectomized patients using either the Provox Vega 22.5 or the Provox ActiValve Light voice prosthesis, with a length of 4, 6, 8, or 10 mm
  • 18 years and older

排除标准

  • Current tracheoesophageal puncture problems such as enlarged puncture or infection
  • Active recurrent or metastatic disease (medical deterioration)
  • The use of ActiValve Strong/XtraStrong or XtraSeal
  • Unable to understand the Patient Information and/or unable to give Informed Consent
  • The previous 2 VPs had a device lifetime > 12 months
  • History of oral resections negatively affecting speech

结局指标

主要结局

Patient acceptability

时间窗: 2 week

Patient recorded acceptability of the voice prosthesis based on study specific questionnaires covering: 1) Experienced stickiness, 2) Effort to speak and 3) maintenance of voice prosthesis. Assessed by Yes/No and multiple choice questions.

次要结局

  • Voice Assessment - Maximum phonation(Baseline and 2 weeks)
  • Voice Assessment - Highest volume(Baseline and 2 weeks)
  • Voice Assessment - Lowest Volume(Baseline and 2 weeks)
  • Quality of Life by EQ-5D-5L(Baseline and 2 weeks)
  • Voice Assessment - Glide tones(Baseline and 2 weeks)
  • Device life(Baseline, and week 52)
  • Voice Assessment - Softness(Baseline and 2 weeks)
  • Voice Assessment - Loudness(Baseline and 2 weeks)
  • Voice Handicap Index - 10(Baseline and 2 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验